Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Akbar Indo Makmur Stimec Tbk (AIMS) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Akbar Indo Makmur Stimec TbkTrade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Akbar Indo Makmur Stimec Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Akbar Indo Makmur Stimec Tbk trades at Rp384 (market cap 86.24B, 288.2K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 7.4× Akbar Indo Makmur Stimec Tbk's market cap, and UBC Medical Indonesia Tbk. is more actively traded (843K versus 288.2K). Which is the better fit depends on your goals.

AIMSLABS
Market Cap
86.24B635.95B
Volume
288.2K843K
Lot
2.88K8.43K
Turnover
112.41M137.6M
Average Price
390.06163.22
Value
112.41M137.6M
Indicative Equilibrium Price
384165
Indicative Equilibrium Volume
30246

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

AIMS
View details
LABS
View details

About Akbar Indo Makmur Stimec Tbk

PT. Akbar Indo Makmur Tbk was established on May 7th 1997. On November 17th, 2000, PT. Stimec merged by PT. Akbar Indo Makmur and changed to be PT. Akbar Indo Makmur Stimec.

Read more on AIMS

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS